Go to deals
Consumer & Retail | Healthcare

Innoxa has sold its eye care activity to Biosynex Group

The private shareholders of Laboratoires Innoxa have sold the company’s eye care activity to Biosynex Group.

Founded in 1920 in Paris by Dr. François Debat, a French pharmacist, Laboratoires Innoxa is a premium brand recognized worldwide for its expertise in the field of ophthalmology and optics. In 2020, the company was acquired by Frédéric and Laetitia Poux, who conducted a complete refoundation of the portfolio. The brand launched its first products in September 2021 and a new patented best-seller – the blue eye drops – in June 2022. Innoxa’s eye care activity now includes seven references with patented formulas, which comply with the latest European health and safety standards. The company’s product portfolio is structured around four areas: eye drops, eye sprays, contactology and optical sprays. The brand distributes its products in several countries, mostly in Europe and Asia, with core markets in France and China. Innoxa has a multichannel strategy with a historical presence in pharmacies and a focus on online platforms such as Amazon.fr and e-parapharmacies.

Founded in 2005, Biosynex is a leading public health player in France and Europe. The group offers innovative healthcare solutions to a wide range of users through two divisions: Biosynex Pharma (specialized in self-diagnostics and family health products) and Biosybex Diagnostic (developing and offering in vitro diagnostic medical devices). The group employs over 500 people, has a presence in 95 countries, and generated approximately US$212 in sales in 2022.

Oaklins’ team in France acted as M&A advisor to Laboratoires Innoxa in this transaction.

Parties

Talk to the deal team

Ludovic Beaulieu

Partner
Paris, France
Oaklins France

Charlotte Delphis

Associate
Paris, France
Oaklins France

Related deals

Venus Wine & Spirit Merchants plc has been acquired by Booker Group Ltd., a subsidiary of Tesco plc
Consumer & Retail | Food & Beverage

Venus Wine & Spirit Merchants plc has been acquired by Booker Group Ltd., a subsidiary of Tesco plc

The shareholders of Venus Wine & Spirit Merchants plc have sold the company to Booker Group Ltd., a subsidiary of Tesco plc. The move allows the Tesco subsidiary to bolster its on-trade portfolio through the addition of Venus’ range of over 2,000 spirits, beers, wines and soft drinks.

Learn more
Leika Medical Equipments Ltd. has been acquired by Angus Capital
Private Equity | Healthcare

Leika Medical Equipments Ltd. has been acquired by Angus Capital

The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.

Learn more
Kees Smit Tuinmeubelen has been acquired by Craft Capital
Private Equity | Consumer & Retail

Kees Smit Tuinmeubelen has been acquired by Craft Capital

Kees Smit Tuinmeubelen, a leading family-owned omnichannel retailer of garden furniture and related accessories, has agreed to sell a majority stake to Craft Capital, a Netherlands-based investment firm. The transaction is still subject to fulfillment of customary closing conditions.

Learn more